Log in to save to my catalogue

In silico evaluation of atazanavir as a potential HIV main protease inhibitor and its comparison wit...

In silico evaluation of atazanavir as a potential HIV main protease inhibitor and its comparison wit...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2666907132

In silico evaluation of atazanavir as a potential HIV main protease inhibitor and its comparison with new designed analogs

About this item

Full title

In silico evaluation of atazanavir as a potential HIV main protease inhibitor and its comparison with new designed analogs

Publisher

United States: Elsevier Ltd

Journal title

Computers in biology and medicine, 2022-06, Vol.145, p.105523-105523, Article 105523

Language

English

Formats

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

AbstractStarting three decades ago and spreading rapidly around the world, acquired immunodeficiency syndrome (AIDS) is an infectious disease distinct from other contagious diseases by its unique ways of transmission. Over the past few decades, research into new drug compounds has been accompanied by extensive advances, and the design and manufactu...

Alternative Titles

Full title

In silico evaluation of atazanavir as a potential HIV main protease inhibitor and its comparison with new designed analogs

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2666907132

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2666907132

Other Identifiers

ISSN

0010-4825

E-ISSN

1879-0534

DOI

10.1016/j.compbiomed.2022.105523

How to access this item